Vimarsana
Biggest News Aggregation in the World

International Expanded News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from International Expanded. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In International Expanded Today - Breaking & Trending Today

Telix Pharmaceuticals Limited: Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging - Vimarsana News

Telix Pharmaceuticals Limited: Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging

Published: June 3, 2024

MELBOURNE, Australia, June 3, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License Application

Source: finanznachrichten.de
Related Topics:
United StatesKyahn WilliamsonCdx ZircaixJames StonecypherAustralian Therapeutic Goods AdministrationTelix Pharmaceuticals LimitedCdx International Expanded AccessAustralian Securities ExchangeDrug AdministrationTelix Pharmaceuticals Limited Disclosure CommitteeHealth CanadaCorporate CommunicationsTelix PharmaceuticalsPrnewswire Telix Pharmaceuticals LimitedPharmaceuticals LimitedBiologics License ApplicationPriority ReviewBreakthrough TherapyChief Development OfficerInternational ExpandedOffering Compassionate UseInvestigational MedicinesIhr Portfolio
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for - Vimarsana News

Telix Completes TLX250-CDx (Zircaix™) BLA Submission for

Published: June 2, 2024

MELBOURNE, Australia, June 03, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has...

Source: globenewswire.com
Related Topics:
United StatesJames StonecypherKyahn WilliamsonCdx ZircaixTelix Pharmaceuticals LimitedCdx International Expanded AccessTelix Pharmaceuticals Limited Disclosure CommitteeAustralian Therapeutic Goods AdministrationHealth CanadaCorporate CommunicationsTelix PharmaceuticalsDrug AdministrationAustralian Securities ExchangePharmaceuticals LimitedBiologics License ApplicationPriority ReviewBreakthrough TherapyChief Development OfficerInternational ExpandedOffering Compassionate UseInvestigational Medicines